General Archive
-
News releasesMRC Technology and Keio University to collaborate on drug discovery
MRC Technology and Keio University School will collaborate to identify promising antibody and small molecule research and translate them into…
-
News releases
Patent protection for biotech/genetic engineering: report
Andrew Farquarson, Director, Technology Transfer, has been a member of the EU Commission’s Expert Group appointed in 2012 to advise on…
-
News releases
Enhancing patient benefit from research spending: MRC Technology and DEBRA Austria sign agreement
MRC Technology, a medical research charity, has signed an agreement to review DEBRA Austria’s research portfolio, aiming to identify promising…
-
News releases
Keytruda receives another breakthrough designation
Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration (FDA) has…
-
News releases
MRC Technology completes move to Stevenage open innovation campus
MRC Technology has completed the move of its Centre for Therapeutics Discovery to state-of-the-art laboratory facilities at the SBC campus.…
-
News releases
MRC Technology appoints two new members to board of trustees
MRC Technology, an independent life science medical research charity, has appointed Dr Les Hughes and Dr Mike Romanos to the…
-
News releases
MRC Technology and Institut Pasteur of Shanghai, Chinese Academy of Sciences collaborate on antibody drug development
MRC Technology and Institut Pasteur of Shanghai, Chinese Academy of Sciences (IPS-CAS) have signed a collaboration agreement to develop new…
-
News releases
MSD joins £4.5 million Dementia Consortium
Dementia Consortium welcomes MSD as a new partner in their global venture to accelerate drug discovery for neurodegenerative disease. MSD…
-
News releases
US team tackle immune system in £875,000 Dementia Consortium project
New dementia drug discovery efforts get underway this month at the University of South Florida, thanks to £875,000 funding from…
-
News releases
Dementia Consortium signs new pharmaceutical partner AbbVie
The Dementia Consortium has welcomed AbbVie as new pharmaceutical partner, joining medical research charity MRC Technology, Alzheimer’s Research UK, the…
-
News releases
New UK-USA collaboration aims to translate more basic research into Alzheimer’s disease treatments
Partnership between MRC Technology and Alzheimer’s Association will focus on finding new ways to translate fundamental research findings into new…
-
News releases
Charity seeks diagnostic partners to deliver new patient treatments
MRC Technology has launched a Call for Diagnostics. It is seeking academic and industry collaborators to develop diagnostic tests in…